Insider · CIK 0001820590

Narula Sanjeev

Reports to the SEC for 3 companies · FLORHAM PARK, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001820590

Forms 4 and 5

Insider transactions

47 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-06	PHATPhathom Pharmaceuticals, Inc.F Tax Payment	Chief Financial & Bus. Officer	FTax Payment	−13.5K sh	$6.78	−$91.4K	214,718
2026-01-02	PHATPhathom Pharmaceuticals, Inc.A Award	Chief Financial & Bus. Officer	AAward	+82.7K sh	—	—	226,715
2026-01-02	PHATPhathom Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Chief Financial & Bus. Officer	AAward	+42.8K sh	—	—	42,848
2025-10-06	PHATPhathom Pharmaceuticals, Inc.A Award	Chief Financial & Bus. Officer	AAward	+144K sh	—	—	144,000
2025-10-06	PHATPhathom Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Chief Financial & Bus. Officer	AAward	+200K sh	—	—	200,000
2025-04-02	Intra-Cellular Therapies, Inc.Stock Option (right to buy)D Disposition to Issuer	Executive Vice President & CFO	DDisposition to Issuer	−17.3K sh	—	—	0
2025-04-02	Intra-Cellular Therapies, Inc.Restricted Stock UnitsD Disposition to Issuer	Executive Vice President & CFO	DDisposition to Issuer	−35K sh	—	—	0
2025-04-02	Intra-Cellular Therapies, Inc.Restricted Stock UnitsD Disposition to Issuer	Executive Vice President & CFO	DDisposition to Issuer	−22.7K sh	—	—	0
2025-02-03	Intra-Cellular Therapies, Inc.Restricted Stock UnitsA Award	Executive Vice President & CFO	AAward	+22.7K sh	—	—	22,727
2024-08-12	Intra-Cellular Therapies, Inc.Stock Option (right to buy)A Award	Executive Vice President & CFO	AAward	+17.3K sh	—	—	17,251
2024-08-12	Intra-Cellular Therapies, Inc.Restricted Stock UnitsA Award	Executive Vice President & CFO	AAward	+35K sh	—	—	35,046
2023-03-04	VTRSViatris IncM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+38.9K sh	—	—	89,996
2023-03-04	VTRSViatris IncF Tax Payment	Chief Financial Officer	FTax Payment	−16.9K sh	$11.13	−$188K	73,087
2023-03-04	VTRSViatris IncM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+1,398 sh	—	—	74,485
2023-03-04	VTRSViatris IncF Tax Payment	Chief Financial Officer	FTax Payment	−608 sh	$11.13	−$6,767.04	73,877
2023-03-04	VTRSViatris Inc · Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−38.9K sh	—	—	77,778
2023-03-04	VTRSViatris Inc · Dividend Equivalent UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−1,397.786 sh	—	—	2,796
2023-03-03	VTRSViatris Inc · Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+116K sh	—	—	116,353
2023-03-02	VTRSViatris IncM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+26.1K sh	—	—	61,299
2023-03-02	VTRSViatris IncF Tax Payment	Chief Financial Officer	FTax Payment	−11.4K sh	$11.13	−$126K	49,939
2023-03-02	VTRSViatris IncM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+2,067 sh	—	—	52,006
2023-03-02	VTRSViatris IncF Tax Payment	Chief Financial Officer	FTax Payment	−899 sh	$11.13	−$10K	51,107
2023-03-02	VTRSViatris Inc · Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−26.1K sh	—	—	26,126
2023-03-02	VTRSViatris Inc · Dividend Equivalent UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−2,066.328 sh	—	—	2,066
2023-02-27	VTRSViatris IncM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+21.2K sh	—	—	43,624
2023-02-27	VTRSViatris IncF Tax Payment	Chief Financial Officer	FTax Payment	−9,326 sh	$11.20	−$104K	34,298
2023-02-27	VTRSViatris IncM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+1,550 sh	—	—	35,848
2023-02-27	VTRSViatris IncF Tax Payment	Chief Financial Officer	FTax Payment	−674 sh	$11.20	−$7,548.8	35,174
2023-02-27	VTRSViatris Inc · Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−21.2K sh	—	—	0
2023-02-27	VTRSViatris Inc · Dividend Equivalent UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−1,549.998 sh	—	—	0
2022-03-21	VTRSViatris Inc · Dividend Equivalent UnitsA Award	Chief Financial Officer	AAward	+251.246 sh	—	—	758.993
2022-03-21	VTRSViatris Inc · Dividend Equivalent UnitsA Award	Chief Financial Officer	AAward	+926.865 sh	—	—	2,175.865
2022-03-04	VTRSViatris Inc · Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+117K sh	—	—	116,667
2022-03-02	VTRSViatris IncM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+26.1K sh	—	—	33,440
2022-03-02	VTRSViatris IncF Tax Payment	Chief Financial Officer	FTax Payment	−11.4K sh	$10.48	−$120K	22,025
2022-03-02	VTRSViatris IncM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+625 sh	—	—	22,650
2022-03-02	VTRSViatris IncF Tax Payment	Chief Financial Officer	FTax Payment	−272 sh	$10.48	−$2,850.56	22,378
2022-03-02	VTRSViatris Inc · Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−26.1K sh	—	—	52,251
2022-03-02	VTRSViatris Inc · Dividend Equivalent UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−624.088 sh	—	—	1,249
2021-12-21	VTRSViatris Inc · Dividend Equivalent UnitsA Award	Chief Financial Officer	AAward	+182.248 sh	—	—	507.746
2021-12-21	VTRSViatris Inc · Dividend Equivalent UnitsA Award	Chief Financial Officer	AAward	+672.316 sh	—	—	1,873.088
2021-09-22	VTRSViatris Inc · Dividend Equivalent UnitsA Award	Chief Financial Officer	AAward	+171.947 sh	—	—	325.499
2021-09-22	VTRSViatris Inc · Dividend Equivalent UnitsA Award	Chief Financial Officer	AAward	+634.316 sh	—	—	1,200.772
2021-06-21	VTRSViatris Inc · Dividend Equivalent UnitsA Award	Chief Financial Officer	AAward	+153.552 sh	—	—	153.552
2021-06-21	VTRSViatris Inc · Dividend Equivalent UnitsA Award	Chief Financial Officer	AAward	+566.457 sh	—	—	566.457
2021-03-02	VTRSViatris Inc · Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+78.4K sh	—	—	78,377
2020-11-20	VTRSViatris Inc · Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+21.2K sh	—	—	21,246

Recent filings

Accepted (ET)
Oct 84
Narula Sanjeev0001193125-26-418114
SEC(opens sec.gov)
Jan 24
Narula Sanjeev0001193125-26-001123
SEC(opens sec.gov)
Oct 84/A
Narula Sanjeev0001193125-25-234650
SEC(opens sec.gov)
Oct 74
Narula Sanjeev0001193125-25-233684
SEC(opens sec.gov)
Apr 24
Narula Sanjeev0000950170-25-049592
SEC(opens sec.gov)
Feb 44
Narula Sanjeev0000950170-25-013670
SEC(opens sec.gov)
Aug 144
Narula Sanjeev0000950170-24-097292
SEC(opens sec.gov)
Mar 64
Narula Sanjeev0000899243-23-007225
SEC(opens sec.gov)

Companies

Address

C/O PHATHOM PHARMACEUTICALS, INC. 100 CAMPUS DRIVE, SUITE 102

FLORHAM PARK, NJ, 07932